miR-124 regulates radiosensitivity of colorectal cancer cells by targeting PRRX1.
- Author:
Shui-Miao LIN
1
;
Qiong XIA
;
Yu-Qin ZHANG
;
Ai-Min SUN
;
Yu-Sheng SHI
;
Lin ZHENG
;
Long-Hua CHEN
Author Information
- Publication Type:Journal Article
- MeSH: Cell Line, Tumor; Colorectal Neoplasms; pathology; radiotherapy; Down-Regulation; Gene Expression Regulation, Neoplastic; Homeodomain Proteins; genetics; metabolism; Humans; Luciferases; MicroRNAs; genetics; metabolism; Radiation Tolerance
- From: Journal of Southern Medical University 2016;36(8):1110-1116
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo detect the expression of miR-124 in colorectal carcinoma (CRC) cells and tissue specimens and analyze its association with the radiosensitivity of the cells.
METHODSThe expression of miR-124 in CRC cell lines and tissues were detected using qRT-PCR. The effect of miR-124 in modulating cell radiosensitivity was assessed in CRC cells with miRNA-124 overexpression and miRNA-124 knockdown, and bioinformatics prediction and dual luciferase reporter system were employed to identify the direct target of miR-124.
RESULTSs miR-124 expression was down-regulated in CRC cell lines and tissues. CRC cells over-expressing miR-124 showed an obviously enhanced radiosensitivity, whereas miR-124 knockdown resulted in a reduced radiosensitivity of the cells. Bioinformatics prediction and dual luciferase reporter system verified PRRX1 as a direct target of miR-124, which regulated the radiosensitivity of CRC cells by directly inhibiting PRRX1.
CONCLUSIONmiR-124 can enhance the radiosensitivity of CRC cells by directly targeting PRRX1, which provides a target for improving the therapeutic effect of radiotherapy of CRC.